Category:CS1 maint: Multiple names: authors list
Jump to navigation
Jump to search
Pages in category "CS1 maint: Multiple names: authors list"
The following 200 pages are in this category, out of 20,562 total.
(previous page) (next page)A
- Adrenal insufficiency classification
- Adrenal insufficiency CT scan
- Adrenal insufficiency MRI
- Adrenal insufficiency overview
- Adrenal insufficiency pathophysiology
- Adrenal insufficiency physical examination
- Adrenal insufficiency resident survival guide
- Adrenal insufficiency x ray
- Adrenal metastases
- Adrenal myelolipoma
- Adrenergic myocarditis
- Adrenergic receptor
- Adrenocortical carcinoma causes
- Adrenocortical carcinoma classification
- Adrenocortical carcinoma CT
- Adrenocortical carcinoma differential diagnosis
- Adrenocortical carcinoma epidemiology and demographics
- Adrenocortical carcinoma historical perspective
- Adrenocortical carcinoma history and symptoms
- Adrenocortical carcinoma laboratory findings
- Adrenocortical carcinoma medical therapy
- Adrenocortical carcinoma MRI
- Adrenocortical carcinoma natural history
- Adrenocortical carcinoma other diagnostic studies
- Adrenocortical carcinoma other imaging studies
- Adrenocortical carcinoma pathophysiology
- Adrenocortical carcinoma physical examination
- Adrenocortical carcinoma radiation therapy
- Adrenocortical carcinoma risk factors
- Adrenocortical carcinoma staging
- Adrenocortical carcinoma surgery
- Adrenoleukodystrophy causes
- Adrenoleukodystrophy CT
- Adrenoleukodystrophy epidemiology and demographics
- Adrenoleukodystrophy future or investigational therapies
- Adrenoleukodystrophy historical perspective
- Adrenoleukodystrophy laboratory findings
- Adrenoleukodystrophy medical therapy
- Adrenoleukodystrophy MRI
- Adrenoleukodystrophy other imaging findings
- Adrenoleukodystrophy physical examination
- Adrenoleukodystrophy screening
- Adrenoleukodystrophy secondary prevention
- Adrenomedullin receptor
- Adrenorphin
- Adult bronchiolitis differential diagnosis
- Adult stem cell
- Adult T-cell leukemia CT
- Adult T-cell leukemia epidemiology and demographics
- Adult T-cell leukemia natural history, complications and prognosis
- Adult T-cell leukemia pathophysiology
- Adult T-cell leukemia risk factors
- Adult treatment panel guidelines (ATP III) for hypercholestrolemia
- Adult vaccinations
- Advance Care Planning
- Advance health care directive
- Advanced Cell Technology
- Advanced glycation endproduct
- Advanced trauma life support
- Adverse drug reaction
- Aedes aegypti
- Aedes albopictus
- Aerobactin synthase
- Aerodynamics
- Aerogel
- Aerometeor radiation astronomy
- Aeropyrum
- Afamelanotide
- AFCAPS/TexCAPS Trial
- Afimoxifene
- AFM (gene)
- AFP-L3
- AFREGS Trial
- African trypanosomiasis differential diagnosis
- African trypanosomiasis laboratory findings
- African trypanosomiasis overview
- Afrotheria
- Aft1p gene transcriptions
- Ag+-exporting ATPase
- Agaricus campestris
- Agatoxin
- AGC box gene transcription laboratory
- AGC box gene transcriptions
- AGCE gene transcriptions
- Ageing
- AGMAT
- Agni casti fructus
- Agomelatine
- Agoraphobia
- Agranulocytosis
- Agronomy
- AHA, ASA guidelines for stroke
- AHA/ASA guideline recommendations for prevention of stroke in women atrial fibrillation
- AHA/ASA guideline recommendations for prevention of stroke in women cerebral venous thrombosis
- AHA/ASA guideline recommendations for prevention of stroke in women menopause and postmenopausal hormonal therapy
- AHA/ASA guideline recommendations for prevention of stroke in women migraine with aura
- AHA/ASA guideline recommendations for prevention of stroke in women obesity, metabolic syndrome, and lifestyle factors
- AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives
- AHA/ASA guideline recommendations for prevention of stroke in women overview
- AHA/ASA guideline recommendations for prevention of stroke in women pregnancy and complications
- AHA/ASA guideline recommendations for prevention of stroke in women prevention
- AHA/ASA guideline recommendations for secondary prevention of stroke
- AHA/ASA Guidelines for the Definition and Evaluation of Transient Ischemic Attack
- Ahrensia
- Aicardi-Goutieres syndrome
- AICDA
- AIDS defining clinical condition
- AIDS dementia complex
- AIDS landmark trials
- AIDS pandemic
- AIDS/references
- AIF1
- AIM-HIGH Trial
- AIP (gene)
- Air embolism causes
- Air embolism CT
- Air embolism differential diagnosis
- Air embolism echocardiography or ultrasound
- Air embolism electrocardiogram
- Air embolism epidemiology and demographics
- Air embolism history and symptoms
- Air embolism laboratory findings
- Air embolism medical therapy
- Air embolism MRI
- Air embolism overview
- Air embolism physical examination
- Air embolism primary prevention
- Air embolism risk factors
- Air embolism secondary prevention
- AIR synthetase (FGAM cyclase)
- Ajuga nipponensis makino
- Akathisia
- AKR1A1
- AKR1C4
- Akshun syndrome
- ALA dehydratase deficiency
- Alagille Syndrome Diagnosis
- Alagille syndrome laboratory findings
- Alagille syndrome laboratory tests
- Alagille syndrome MRI
- Alagille syndrome natural history
- Alagille syndrome overview
- Alagille syndrome pathophysiology
- Alagille syndrome physical examination
- Alagille syndrome surgery
- Alanine-glyoxylate transaminase
- Alanopine dehydrogenase
- Alanylphosphatidylglycerol synthase
- Alaproclate
- Alatrofloxacin
- Albendazole monooxygenase
- Albert Einstein
- Albidovulum
- Albinism causes
- Albinism epidemiology and demographics
- Albinism historical perspective
- Albinism laboratory findings
- Albinism medical therapy
- Albinism natural history, complications and prognosis
- Albinism other diagnostic studies
- Albinism other imaging findings
- Albinism pathophysiology
- Albinism physical examination
- Alcohol dehydrogenase (acceptor)
- Alcohol detoxification
- Alcohol O-cinnamoyltransferase
- Alcohol withdrawal causes
- Alcohol withdrawal classification
- Alcohol withdrawal cost-effectiveness of therapy
- Alcohol withdrawal CT
- Alcohol withdrawal diagnostic criteria
- Alcohol withdrawal differential diagnosis
- Alcohol withdrawal future or investigational therapies
- Alcohol withdrawal historical perspective
- Alcohol withdrawal laboratory findings
- Alcohol withdrawal medical therapy
- Alcohol withdrawal natural history, complications and prognosis
- Alcohol withdrawal other diagnostic studies
- Alcohol withdrawal other imaging findings
- Alcohol withdrawal overview
- Alcohol withdrawal pathophysiology
- Alcohol withdrawal physical examination
- Alcohol withdrawal secondary prevention
- Alcoholic cardiomyopathy echocardiography
- Alcoholic cardiomyopathy epidemiology and demographics
- Alcoholic cardiomyopathy laboratory findings
- Alcoholic cardiomyopathy medical therapy
- Alcoholic cardiomyopathy natural history, complications and prognosis
- Alcoholic cardiomyopathy overview
- Alcoholic cardiomyopathy pathophysiology
- Alcoholic hepatitis causes
- Alcoholic hepatitis CT
- Alcoholic hepatitis epidemiology and demographics
- Alcoholic hepatitis MRI
- Alcoholic hepatitis natural history, complications and prognosis
- Alcoholic hepatitis other diagnostic studies
- Alcoholic hepatitis pathophysiology
- Alcoholic hepatitis primary prevention
- Alcoholic hepatitis risk factors
- Alcoholic hepatitis screening
Media in category "CS1 maint: Multiple names: authors list"
The following 11 files are in this category, out of 11 total.
-
1a3p egf.png 1,440 × 1,080; 241 KB
-
AHR functional domains.svg 1,500 × 400; 22 KB
-
Aldose reductase 1us0.png 1,000 × 878; 499 KB
-
ARISE Trial - lactate values.png 467 × 272; 9 KB
-
Aromatase 3EQM.png 1,440 × 1,080; 732 KB
-
Catechol-O-methyl transferase 3bwm.png 1,200 × 890; 488 KB
-
Cochrane.2020.pmid.32584464.png 596 × 407; 19 KB
-
COVID-19 - Dx testing.png 475 × 333; 15 KB
-
HoxB1-Pbx1 heterodimer binding DNA 1b72.png 1,000 × 1,321; 601 KB
-
NCEP guidelines.png 960 × 720; 14 KB
-
Table LDL goal.png 960 × 720; 4 KB
